Neil Gesundheit Net Worth

The estimated Net Worth of Neil Gesundheit is at least 59.6 千$ dollars as of 14 January 2005. Neil Gesundheit owns over 8,665 units of VIVUS stock worth over 59,550$ and over the last 21 years Neil sold VVUS stock worth over 0$.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Neil Gesundheit VVUS stock SEC Form 4 insiders trading

Neil has made over 1 trades of the VIVUS stock since 2005, according to the Form 4 filled with the SEC. Most recently Neil exercised 8,665 units of VVUS stock worth 25,475$ on 14 January 2005.

The largest trade Neil's ever made was exercising 8,665 units of VIVUS stock on 14 January 2005 worth over 25,475$. On average, Neil trades about 2,166 units every 0 days since 2004. As of 14 January 2005 Neil still owns at least 127,653 units of VIVUS stock.

You can see the complete history of Neil Gesundheit stock trades at the bottom of the page.

What's Neil Gesundheit's mailing address?

Neil's mailing address filed with the SEC is , , , , .

Insiders trading at VIVUS

Over the last 21 years, insiders at VIVUS have traded over 6,261,269$ worth of VIVUS stock and bought 5,180,746 units worth 13,074,554$ . The most active insiders traders include Tide Capital, Llc North Tid...、Alexander J Denner、Ernest Mario. On average, VIVUS executives and independent directors trade stock every 39 days with the average trade being worth of 35,394$. The most recent stock trade was executed by John P. Amos on 1 March 2019, trading 11,000 units of VVUS stock currently worth 53,350$.

What does VIVUS do?

VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.

Complete history of Neil Gesundheit stock trades at VIVUS

VIVUS executives and stock owners

VIVUS executives and other stock owners filed with the SEC include:

• John Amos,
  Chief Executive Officer, Director
• John Slebir,
  Senior Vice President - Business Development, General Counsel, Secretary
• Santosh Varghese,
  Senior Vice President, Chief Medical Officer
• Mark Oki,
  Chief Financial Officer, Senior Vice President, Chief Accounting Officer
• Thomas King,
  Independent Director
• David Norton,
  Independent Chairman of the Board
• Jill Frizzley,
  Independent Director
• Herman Rosenman,
  Independent Director
• Jorge Plutzky,
  Independent Director
• Edward Kangas,
  Independent Director
• Karen Ferrell,
  Independent Director
• Allan Shaw,
  Director
• Herm Rosenman,
  Director
• Eric W Roberts,
  Director
• Tide Capital, Llc North Tid...,
  
• Seth H. Z. Fischer,
  Chief Executive Officer
• Mayu Sris,
  Director
• Kenneth Suh,
  President
• Wesley Day,
  Vice President, Clinical
• Michael /Ny/ Miller,
  Chief Commercial Officer
• Wang Changjin,
  VP, Business Development
• Virgil A Place,
  Chairman & CSO
• Graham Strachan,
  Director
• Samuel F Colin,
  Director
• Ernest Mario,
  Director
• Anthony P. Zook,
  Chief Executive Officer
• John W Dietrich,
  Vice President, R & D
• Terry Nida,
  VP, Worldwide Marketing/
• Svai S Sanford,
  Interim CFO
• Mario M Rosati,
  Director
• Alexander J Denner,
  Director
• Jon C Biro,
  10% owner
• J Martin Carroll,
  Director
• Robert N Wilson,
  Director
• Alexander J Sarissa Capital...,
  
• M. Scott Oehrlein,
  Chief Operations Officer
• Timothy E Morris,
  VP, Finance and CFO
• Leland F Wilson,
  President & CEO
• Linda M Dairiki Shortliffe,
  Director
• Charles J Casamento,
  Director
• Lee Perry,
  Vice President & Chief
• Jacob Pieter Kastelein Joha...,
  Director
• Michael J Astrue,
  Director
• Mark B Logan,
  Director
• Michael Patrick Miller,
  SVP, Chief Commercial Officer
• Guy P Marsh,
  VP, Operations & General Mgr.
• Neil Gesundheit,
  VP, Chief Medical Officer
• Larry J Strauss,
  Vice President, Finance & CFO
• James R Nickel,
  Vice President, Clinical
• Peter Y Tam,
  VP, Business Planning
• Carol Zoltowski,
  Vice President, Regulatory
• Lori Forrest,
  VP, Operations & General Mgr.